Cargando…
Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial
BACKGROUND: Bacterial vaginosis might increase HIV risk by eliciting genital inflammation and epithelial barrier disruption, whereas vaginal Lactobacillus crispatus is associated with immune quiescence and HIV protection. We investigated the effect of a live biotherapeutic containing L crispatus CTV...
Autores principales: | Armstrong, Eric, Hemmerling, Anke, Miller, Steve, Burke, Kerianne E, Newmann, Sara J, Morris, Sheldon R, Reno, Hilary, Huibner, Sanja, Kulikova, Maria, Nagelkerke, Nico, Coburn, Bryan, Cohen, Craig R, Kaul, Rupert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188188/ https://www.ncbi.nlm.nih.gov/pubmed/35659905 http://dx.doi.org/10.1016/S2666-5247(22)00043-X |
Ejemplares similares
-
Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis–associated bacteria rather than lactobacilli
por: Armstrong, Eric, et al.
Publicado: (2022) -
Treatment Success Following Standard Antibiotic Treatment for Bacterial Vaginosis Is Not Associated With Pretreatment Genital Immune or Microbial Parameters
por: Armstrong, Eric, et al.
Publicado: (2023) -
Cytoprotective Effect of Lactobacillus crispatus CTV-05 against Uropathogenic E. coli
por: Butler, Daniel S. C., et al.
Publicado: (2016) -
Lactine as an Article of Nutrition
Publicado: (1853) -
Log (Lactobacillus crispatus/ Gardnerella vaginalis): a new indicator of diagnosing bacterial vaginosis
por: Deng, Tongyang, et al.
Publicado: (2022)